0001562180-19-005773.txt : 20191129
0001562180-19-005773.hdr.sgml : 20191129
20191129134447
ACCESSION NUMBER: 0001562180-19-005773
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20191126
FILED AS OF DATE: 20191129
DATE AS OF CHANGE: 20191129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MEIER RICHARD A
CENTRAL INDEX KEY: 0001227305
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36545
FILM NUMBER: 191260815
MAIL ADDRESS:
STREET 1: 1700 E ST ANDREW PLACE
CITY: SANTA ANA
STATE: CA
ZIP: 92705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intersect ENT, Inc.
CENTRAL INDEX KEY: 0001271214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 200280837
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-641-2100
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: SINEXUS INC
DATE OF NAME CHANGE: 20031124
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-11-26
false
0001271214
Intersect ENT, Inc.
XENT
0001227305
MEIER RICHARD A
C/O INTERSECT ENT, INC.
1555 ADAMS DRIVE
MENLO PARK
CA
94025
false
true
false
false
EVP & Chief Financial Officer
Common Stock
2019-11-26
4
A
false
52241.00
0.00
A
52241.00
D
Common Stock
2019-11-26
4
A
false
57230.00
0.00
A
109471.00
D
Stock Options (Right to buy)
21.60
2019-11-26
4
A
false
74852.00
0.00
A
2029-11-26
Common Stock
74852.00
74852.00
D
Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing one year after the grant date.
Restricted stock units.
Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units shall vest on the third anniversary from the date of grant provided that certain 30-day trailing average stock price (the "Average Closing Price") targets are achieved at any time during the three year period following the date of grant. 33 1/3%, 66 2/3% or 100% of the shares will vest if the Average Closing Price equals or exceeds specific stock price targets.
Restricted stock units, of which 57,230 are performance based.
The vesting commencement date of the option is November 26, 2019. 1/4th of the shares subject to the option shall vest on November 26, 2020 and 1/48th of the shares subject to the option shall vest monthly thereafter over 36 months.
/s/ David A. Lehman, Attorney-in-Fact for Richard A Meier
2019-11-29
EX-24
2
poarichardmeier.txt
POWER OF ATTORNEY
POWER OF ATTORNEY
Know all by these present, that the undersigned hereby
constitutes and appoints each of THOMAS A. WEST and DAVID A. LEHMAN,
signing individually, the undersigned's true and lawful
attorneys-in fact and agents to:
(1) execute for and on behalf of the undersigned, in
the undersigned's capacity as an officer, director or
beneficial owner of more than 10% of a registered class of
securities of Intersect ENT, Inc. (the "Company"), (a)
Forms 3, 4 and 5 (including any amendments thereto) in
accordance with Section 16(a) of the Securities Exchange
Act of 1934, as amended (the "Exchange Act") and the rules
thereunder and a (b) Form ID, Uniform Application for
Access Codes to File on EDGAR;
(2) do and perform any and all acts for and on behalf
of the undersigned that may be necessary or desirable to
execute such Forms 3, 4 or 5 or Form ID (including any
amendments thereto) and timely file such forms with the
United States Securities and Exchange Commission and any
stock exchange or similar authority; and
(3) take any other action of any nature whatsoever in
connection with the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit, in the best interest
of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-
fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms
and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform any and every act and
thing whatsoever requisite, necessary or proper to be done in
the exercise of any of the rights and powers herein granted, as
fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution
or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of
this power of attorney and the rights and powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-
fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any
of the undersigned's responsibilities to comply with Section 16
of the Exchange Act.
This Power of Attorney shall remain in full force and
effect until the earliest to occur of (a) the undersigned is no
longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued
by the Company, (b) revocation by the undersigned in a signed
writing delivered to the foregoing attorneys-in-fact or (c) as
to any attorney-in-fact individually, until such attorney-in-
fact is no longer employed by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of November 26th, 2019.
/s/ Richard A Meier
Richard A. Meier
1
108990461 v1